The UK Medicines and Healthcare products Regulatory Agency (MHRA) recently approved Amgen’s bone cancer drug Xgeva (denosumab), the first drug submitted through the international recognition procedure ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has authorised the use of nipocalimab (Imaavy, Janssen) to treat adults and adolescents aged 12 and over with generalised myasthenia ...
Adults with familial chylomicronaemia syndrome (FCS) — a rare inherited condition that can cause life-threatening pancreatic inflammation — are a step closer to a new treatment option following ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results